Radiopharma is rapidly evolving to meet rising patient demand. Radiopharmaceutical’s unique ability to diagnose and treat is unlocking new possibilities, but the future depends on how science, industry players and healthcare companies collaborate. 
 

Cristiana Gameiro, PhD, Radiochemistry Domain Expert & IBA Fellow
Jean-Michel Geets, Principal Domain Expert & IBA Fellow
Louise Piron, Marketing Manager